Physical Activity and Other Strategies in Treatment of Buerger’s Disease - a Systematic Review
DOI:
https://doi.org/10.12775/QS.2026.52.69726Keywords
Buerger’s disease, Thromboangitis obliterans, Peripheral arterial disease, Ischemia, Treatment optionsAbstract
Buerger's disease, also known as Thromboangitis obliterans (TAO), is a nonatherosclerotic vascular disorder of unknown etiology, causing distal arterial occlusions. Implication of changes in the vessels is decreased blood flow and ischemia as the result. Buerger’s disease is entirely associated with smoking. Diagnosis of TAO is challenging. Multiple diagnostic criteria have been suggested in the past years. Therefore it is advisable to base diagnosis on unified Delphi criteria. Patients suffering from TAO may present pain in digits as an early symptom, whereas late symptoms may include ulcers, gangrene and intermittent claudication. Current management of TAO lacks standard guidelines. There is no one satisfying strategy, which can be implemented in every single patient. Various conservative and surgical methods might be performed. Each one has its own advantages and disadvantages. To this very day, tobacco cessation is the cornerstone of the treatment. Important, although frequently neglected aspect is an exercise therapy. Modern, satisfying treatment methods are constantly explored.
References
1. Merashli M, Bucci T, Pastori D, Pignatelli P, Arcaro A, Gentile F, Marottoli V, Ames PRJ. A Meta-Analysis of Plasma Homocysteine in Buerger's Disease. Thromb Haemost. 2022 Jul;122(7):1243-1246. doi: 10.1055/s-0041-1742165. Epub 2022 Jan 20. PMID: 35052008.
2. Pilitsi E, Kennamer B, Trepanowski N, Gonzalez R, Trojanowski M, Phillips T, Lam CS. Cannabis arteritis presenting with Raynaud's and digital ulcerations: a case-based review of a controversial thromboangiitis obliterans-like condition. Clin Rheumatol. 2023 Jul;42(7):1981-1985. doi: 10.1007/s10067-023-06603-x. Epub 2023 Apr 25. PMID: 37097526.
3. Buerger's disease in the 21st century: diagnosis, clinical features, and therapy. Mills JL Sr. Semin Vasc Surg. 2003;16:179–189. doi: 10.1016/s0895-7967(03)00023-1.
4. Fazeli B. Buerger’s disease as an indicator of socioeconomic development in different societies, a cross-sectional descriptive study in the North-East of Iran. Arch Med Sci 2010;6:343–7.
5. Idei N, Nishioka K, Soga J, Hidaka T, Hata T, Fujii Y, Fujimura N, Maruhashi T, Mikami S, Teragawa H, Kihara Y, Noma K, Chayama K, Higashi Y. Vascular function and circulating progenitor cells in thromboangitis obliterans (Buerger's disease) and atherosclerosis obliterans. Hypertension. 2011 Jan;57(1):70-8. doi: 10.1161/HYPERTENSIONAHA.110.163683. Epub 2010 Nov 29. PMID: 21115876.
6. Zheng P, Chen SJ, Shao HZ. Studies on hypercoagulation state in thromboangiitis obliterans. Chin Med J (Engl) 1989; 102 (01) 67-71
7. Qaja E, Muco E, Hashmi MF. Buerger Disease. In: StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing; 2020
8. Undas A, Nowakowski T, Cieśla-Dul M, Sadowski J. Abnormal plasma fibrin clot characteristics are associated with worse clinical outcome in patients with peripheral arterial disease and thromboangiitis obliterans. Atherosclerosis 2011; 215 (02) 481-486
9. Fazeli B, Rafatpanah H, Ravari H, Hosseini RF, Rezaee SA. Investigation of the expression of mediators of neovascularization from mononuclear leukocytes in thromboangiitis obliterans. Vascular. 2014 Jun;22(3):174-80. doi: 10.1177/1708538113477068. PMID: 23567329.
10. Halacheva K, Gulubova MV, Manolova I, Petkov D. Expression of ICAM-1, VCAM-1, E-selectin and TNF-alpha on the endothelium of femoral and iliac arteries in thromboangiitis obliterans. Acta Histochem. 2002;104(2):177-84. doi: 10.1078/0065-1281-00621. PMID: 12086338.
11. Klein-Weigel P, Volz TS, Zange L, Richter J. Buerger's disease: providing integrated care. J Multidiscip Healthc. 2016 Oct 12;9:511-518. doi: 10.2147/JMDH.S109985. PMID: 27785045; PMCID: PMC5067065.
12. Puéchal X, Fiessinger JN. Thromboangiitis obliterans or Buerger's disease: challenges for the rheumatologist. Rheumatology (Oxford). 2007 Feb;46(2):192-9. doi: 10.1093/rheumatology/kel388. Epub 2006 Nov 20. PMID: 17116654.
13. Starace MVR, Alessandrini A, Tosti A, Piraccini BM. Nails Involvement in Winiwarter-Buerger Disease. Skin Appendage Disord. 2022 Mar;8(2):142-145. doi: 10.1159/000518982. Epub 2021 Sep 21. PMID: 35415181; PMCID: PMC8928203.
14. Szydełko-Paśko U, Przeździecka-Dołyk J, Małecki R, Szuba A, Misiuk-Hojło M. Ocular Manifestations of Buerger's Disease - A Review of Current Knowledge. Clin Ophthalmol. 2022 Mar 18;16:851-860. doi: 10.2147/OPTH.S352608. PMID: 35330748; PMCID: PMC8939870.
15. Fazeli B, Poredos P, Kozak M, Pecsvarady Z, Catalano M, Al Salman MM, Altarazi L, Ali AA, Bashar AH, Bozkurt K, Cacione D, Chua B, Cvjetko I, Desai S, Erer D, Farkas K, Gaddikeri P, Geroulakos G, Guclu O, Hussein E, Ionac M, Iwai T, Karahan O, Kashani D, Kota A, Kroger K, Kubat E, Kumar PP, Lang W, Lobastov K, Malecki R, Marcoccia A, Ozbakkaloglu A, Pandey SR, Patel M, Polat A, Rajeev A, Ravari H, Samuel V, Schernthaner G, Selvaraj D, Sanri US, Sermsathanasawadi N, Sharebiani H, Stanek A, Stephen E, Szuba A, Taha W, Taheri H, Wautrecht JC, Yuwono HS, Zor MH, Liew A. Diagnostic criteria for Buerger's disease: International Consensus of VAS - European Independent Foundation in Angiology/Vascular Medicine. Int Angiol. 2023 Oct;42(5):396-401. doi: 10.23736/S0392-9590.23.05098-8. PMID: 38010012.
16. Farberow NL, Nehemkis AM. Indirect self-destructive behavior in patients with Buerger’s disease. J Pers Assess. 1979;43(1):86–96. doi: 10.1207/s15327752jpa4301_12.
17. Shionoya S. Diagnostic criteria of Buerger’s disease. Int J Cardiol 1998;66(Suppl 1):S243–5, discussion S247.
18. Karra S, Jinna S, Desai H. Migratory Thrombophlebitis. 2025 Sep 14. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 31613482.
19. Buerger L. The circulatory disturbances of the extremities. First edition. Philadelphia, PA: W.B. Saunders; 1924.
20. Piazza G, Creager MA. Thromboangiitis obliterans. Circulation. 2010 Apr 27;121(16):1858-61. doi: 10.1161/CIRCULATIONAHA.110.942383. PMID: 20421527; PMCID: PMC2880529.
21. Hersi M, Beck A, Hamel C, Esmaeilisaraji L, Pussegoda K, Austin B, Ahmadzai N, Pratt M, Thuku M, Yazdi F, Bennett A, Shaver N, Vyas N, Skidmore B, Hutton B, Manuel D, Morrow M, Pakhale S, Presseau J, Shea BJ, Little J, Moher D, Stevens A. Effectiveness of smoking cessation interventions among adults: an overview of systematic reviews. Syst Rev. 2024 Jul 12;13(1):179. doi: 10.1186/s13643-024-02570-9. PMID: 38997788; PMCID: PMC11242003.
22. Arkkila PE. Thromboangiitis obliterans (Buerger's disease). Orphanet J Rare Dis. 2006 Apr 27;1:14. doi: 10.1186/1750-1172-1-14. PMID: 16722538; PMCID: PMC1523324.
23. Cacione DG, Macedo CR, do Carmo Novaes F, Baptista-Silva JC. Pharmacological treatment for Buerger's disease. Cochrane Database Syst Rev. 2020 May 4;5(5):CD011033. doi: 10.1002/14651858.CD011033.pub4. PMID: 32364620; PMCID: PMC7197514.
24. Arandjelovic, A., Awad, A., Nicolopoulos, J. and Dolianitis, C. (2025), Buerger's Disease: Successful Management of Acute Cutaneous Features and Achieving Disease Remission With Pentoxifylline. Australas J Dermatol, 66: e466-e470. https://doi.org/10.1111/ajd.14593
25. Kobiyama K, Ley K. Atherosclerosis. Circ Res. 2018 Oct 26;123(10):1118-1120. doi: 10.1161/CIRCRESAHA.118.313816. PMID: 30359201; PMCID: PMC6298754.
26. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
on behalf of the TASC II Working Group et al.
Journal of Vascular Surgery, Volume 45, Issue 1, S5 - S67
27. Palmer-Kazen U, Wahlberg E. Arteriogenesis in peripheral arterial disease. Endothelium. 2003;10(4-5):225-32. doi: 10.1080/10623320390246360. PMID: 14660082.
28. Haas TL, Lloyd PG, Yang HT, Terjung RL. Exercise training and peripheral arterial disease. Compr Physiol. 2012 Oct;2(4):2933-3017. doi: 10.1002/cphy.c110065. PMID: 23720270; PMCID: PMC3767482.
29. Komiya D, Iwai K, Ohno T. Efficacy of Supervised Exercise Therapy for Intermittent Claudication in a Case With Buerger's Disease. Cureus. 2023 Aug 15;15(8):e43537. doi: 10.7759/cureus.43537. PMID: 37719627; PMCID: PMC10501807.
30. Donas KP, Schulte S, Ktenidis K, Horsch S. The role of epidural spinal cord stimulation in the treatment of Buerger's disease. J Vasc Surg. 2005 May;41(5):830-6. doi: 10.1016/j.jvs.2005.01.044. PMID: 15886668.
31. Chierichetti F, Mambrini S, Bagliani A, Odero A. Treatment of Buerger's disease with electrical spinal cord stimulation--review of three cases. Angiology. 2002 May-Jun;53(3):341-7. doi: 10.1177/000331970205300313. PMID: 12025923.
32. Kacmaz F, Kaya A, Keskin M, Keceoglu S, Algin IH, Yilmazkaya B, Ilkay E. Clinical outcomes of extended endovascular recanalization of 16 consecutive Buerger's disease patients. Vascular. 2019 Jun;27(3):233-241. doi: 10.1177/1708538118805623. Epub 2018 Oct 10. PMID: 30305010.
33. Lee JH, Ko YG, Choi D. Endovascular Treatment of Multilevel Chronic Total Occlusion Using a Stent Puncture Technique in Buerger's Disease. Korean Circ J. 2016 May;46(3):417-20. doi: 10.4070/kcj.2016.46.3.417. Epub 2016 Apr 26. PMID: 27275180; PMCID: PMC4891608.
34. Serefli D, Saydam O. Endovascular treatment of Buerger's disease in patients with critical limb ischaemia. Cardiovasc J Afr. 2022 Sep-Oct 23;33(5):254-259. doi: 10.5830/CVJA-2022-018. Epub 2022 Jun 30. PMID: 35789369; PMCID: PMC9887440.
35. Modaghegh MS, Hafezi S. Endovascular Treatment of Thromboangiitis Obliterans (Buerger's Disease). Vasc Endovascular Surg. 2018 Feb;52(2):124-130. doi: 10.1177/1538574417744085. Epub 2017 Dec 13. PMID: 29237360.
36. Zheng, G., Xie, H., Lai, M., & Liu, X. (2024). Short-term efficacy of endovascular procedures for lower extremity thromboangiitis obliterans (Buerger’s disease). Postgraduate Medicine, 136(5), 577–583. https://doi.org/10.1080/00325481.2024.2373678
37. Graziani L, Piaggesi A. Indications and clinical outcomes for below knee endovascular therapy: review article. Catheter Cardiovasc Interv. 2010 Feb 15;75(3):433-43. doi: 10.1002/ccd.22287. PMID: 19937784.
38. Kodama A, Takahashi N, Sugimoto M, Niimi K, Banno H, Komori K. Three cases of dorsal metatarsal artery bypass in patients with Buerger disease. J Vasc Surg Cases Innov Tech. 2018 Aug 17;4(3):185-188. doi: 10.1016/j.jvscit.2018.03.011. PMID: 30148235; PMCID: PMC6105765.
39. Salimi J, Cheraghali R, Omrani Z, Farshidmehr P, Afghani R. Surgical Treatment Options for Buerger's Disease (Experience with 315 Cases in Iran). Med J Islam Repub Iran. 2022 Nov 14;36:134. doi: 10.47176/mjiri.36.134. PMID: 36479532; PMCID: PMC9719581.
40. Sayin A, Bozkurt AK, Tüzün H, Vural FS, Erdog G, Ozer M. Surgical treatment of Buerger's disease: experience with 216 patients. Cardiovasc Surg. 1993 Aug;1(4):377-80. PMID: 8076063.
41. Ozcan A, Conermann T. Lumbar Sympatholysis. 2022 Oct 31. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 32809349
42. Karanth VKL, Karanth TK, Karanth L. Lumbar sympathectomy techniques for critical lower limb ischaemia due to non‐reconstructable peripheral arterial disease. Cochrane Database of Systematic Reviews 2016, Issue 12. Art. No.: CD011519. DOI: 10.1002/14651858.CD011519.pub2. Accessed 23 February 2026.
43. Clinical Outcomes of Chemical Lumbar Sympathectomy Versus Revascularisation in Patients with Chronic Limb Threatening Ischaemia due to Thromboangiitis Obliterans
Wei, Ming et al., European Journal of Vascular and Endovascular Surgery, Volume 70, Issue 6, 845 – 846
44. Shimizu Y, Murohara T. Therapeutic Angiogenesis for Thromboangiitis Obliterans. Circ J. 2023 Aug 25;87(9):1238-1239. doi: 10.1253/circj.CJ-23-0157. Epub 2023 Mar 31. PMID: 37005248.
45. Ayumu Fujioka, Kenji Yanishi, Arito Yukawa, Kojiro Imai, Isao Yokota, Kei Fujikawa, Ayumu Yamada, Akari Naito, Keisuke Shoji, Hirofumi Kawamata, Yukihito Higashi, Tomoaki Ishigami, Ken-ichiro Sasaki, Syuhei Tara, Koichiro Kuwahara, Satoshi Teramukai, Satoaki Matoba, A Multicenter Prospective Interventional Trial of Therapeutic Angiogenesis Using Bone Marrow-Derived Mononuclear Cell Implantation for Patients With Critical Limb-Threatening Ischemia Caused by Thromboangiitis Obliterans, Circulation Journal, 2023, Volume 87, Issue 9, Pages 1229-1237, Released on J-STAGE August 25, 2023, Advance online publication March 10, 2023, Online ISSN 1347-4820, Print ISSN 1346-9843, https://doi.org/10.1253/circj.CJ-23-0046,
46. Beltrán-Camacho L, Rojas-Torres M, Durán-Ruiz MC. Current Status of Angiogenic Cell Therapy and Related Strategies Applied in Critical Limb Ischemia. Int J Mol Sci. 2021 Feb 26;22(5):2335. doi: 10.3390/ijms22052335. PMID: 33652743; PMCID: PMC7956816.
47. Barć P, Lubieniecki P, Antkiewicz M, Kupczyńska D, Barć J, Frączkowska-Sioma K, Dawiskiba T, Dorobisz T, Sekula W, Czuwara B, Małodobra-Mazur M, Baczyńska D, Witkiewicz W, Skóra JP, Janczak D. Gene Therapy of Thromboangiitis Obliterans with Growth Factor Plasmid (VEGF165) and Autologous Bone Marrow Cells. Biomedicines. 2024 Jul 6;12(7):1506. doi: 10.3390/biomedicines12071506. PMID: 39062079; PMCID: PMC11275074.
48. Skóra J, Pupka A, Janczak D, Barć P, Dawiskiba T, Korta K, Baczyńska D, Mastalerz-Migas A, Garcarek J. Combined autologous bone marrow mononuclear cell and gene therapy as the last resort for patients with critical limb ischemia. Arch Med Sci. 2015 Apr 25;11(2):325-31. doi: 10.5114/aoms.2013.39935. Epub 2014 Jul 23. PMID: 25995748; PMCID: PMC4424239.
49. Inan M, Alat I, Kutlu R, Harma A, Germen B. Successful treatment of Buerger's Disease with intramedullary K-wire: the results of the first 11 extremities. Eur J Vasc Endovasc Surg. 2005 Mar;29(3):277-80. doi: 10.1016/j.ejvs.2004.12.011. PMID: 15694801.
50. Patwa JJ, Krishnan A. Buerger's Disease (Thromboangiitis Obliterans)- Management by Ilizarov's Technique of Horizontal Distraction. A Retrospective Study of 60 Cases. Indian J Surg. 2011 Jan;73(1):40-7. doi: 10.1007/s12262-010-0186-1. Epub 2010 Dec 14. PMID: 22211037; PMCID: PMC3077184.
51. Mohamad Yusoff, F., Kajikawa, M., Yamaji, T. et al. Low-intensity pulsed ultrasound improves symptoms in patients with Buerger disease: a double-blinded, randomized, and placebo-controlled study. Sci Rep 14, 13704 (2024).
52. Baumann G, Stangl V, Klein-Weigel P, Stangl K, Laule M, Enke-Melzer K. Successful treatment of thromboangiitis obliterans (Buerger's disease) with immunoadsorption: results of a pilot study. Clin Res Cardiol. 2011 Aug;100(8):683-90. doi: 10.1007/s00392-011-0298-z. Epub 2011 Mar 5. PMID: 21380608
53. Klein-Weigel PF, Köning C, Härtwig A, Krüger K, Gutsche-Petrak B, Dreusicke S, Thieme U, Enke-Melzer K, Urbach B, Kron J. Immunadsorption bei Thrombangiitis obliterans - eine vielversprechende therapeutische Option. Behandlungsergebnisse einer konsekutiven Patientenkohorte der klinischen Routineversorgung [Immunoadsorption in thrombangiitis obliterans: a promising therapeutic option: results of a consecutive patient cohort treated in clinical routine care]. Zentralbl Chir. 2012 Oct;137(5):460-5. German. doi: 10.1055/s-0032-1315141. Epub 2012 Nov 7. PMID: 23136105.
54. Tselmin, S., Julius, U., Bornstein, S. R., & Hohenstein, B. (2017). Low rate of infectious complications following immunoadsorption therapy without regular substitution of intravenous immunoglobulins. Atherosclerosis. Supplements, 30, 278–282.
55. De Haro J, Acin F, Bleda S, Varela C, Esparza L. Treatment of thromboangiitis obliterans (Buerger's disease) with bosentan. BMC Cardiovasc Disord. 2012 Feb 14;12:5. doi: 10.1186/1471-2261-12-5. PMID: 22333218; PMCID: PMC3306190.
56. Denton CP, Pope JE, Peter HH, Gabrielli A, Boonstra A, van den Hoogen FH, Riemekasten G, De Vita S, Morganti A, Dölberg M, Berkani O, Guillevin L; TRacleer Use in PAH associated with Scleroderma and Connective Tissue Diseases (TRUST) Investigators. Long-term effects of bosentan on quality of life, survival, safety and tolerability in pulmonary arterial hypertension related to connective tissue diseases. Ann Rheum Dis. 2008 Sep;67(9):1222-8. doi: 10.1136/ard.2007.079921. Epub 2007 Nov 30. PMID: 18055477; PMCID: PMC2564804.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Julia Kaczmarek, Michał Błażuk, Katarzyna Barczyńska, Rafał Ejsner, Aleksandra Grelowska, Adrian Ołubiec, Aleksandra Oto, Nela Poznańska, Tomasz Sys
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 132
Number of citations: 0
